by Matthew Johnson | Aug 3, 2021 | PTAB News
By Matt Johnson – On July 6th and 7th, the USPTO made good on its promise to not wait for a confirmed director to begin Arthrex Director reviews, issuing its first denials of review requests. The full press release is below: USPTO issues first Director...
by Matthew Johnson | Jul 21, 2021 | PTAB News
By Matt Johnson – On July 20th, the PTAB provided additional clarifications regarding its views on Arthrex and how its interim procedures for requesting Director review will work for cases receiving Final Written Decisions on a going forward basis (i.e., not...
by Matthew Johnson | Jul 21, 2021 | PTAB News
The United States Supreme Court has delivered its decision in U.S. v. Arthrex, which determined whether appointments of administrative patent judges to the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board (PTAB) were constitutional. Jones Day’s Matt...
by Matthew Johnson | Jun 30, 2021 | Federal Circuit Appeal, PTAB News
By Matt Johnson – On June 29th, the PTO issued an initial protocol for requesting Director review of a PTAB Final Written Decision according to the Supreme Court’s Arthrex decision. This Arthrex protocol is similar to the current procedure for requesting...
by Greg Castanias | Jun 23, 2021 | PTAB News
By Greg Castanias, Dave Cochran, Steph Mishaga, and Alex Chung – In United States v. Arthrex Inc., the U.S. Supreme Court agreed with the Federal Circuit that the pre-Arthrex Patent Trial and Appeal Board (PTAB) regime of Administrative Patent Judge decisions...
